Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2010
09/30/2010US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses
09/30/2010US20100249031 Nutritional Composition Comprising Curcuminoids and Methods of Manufacture
09/30/2010US20100249023 Isoflavone formulation
09/30/2010US20100249020 Fast-acting insulin formulation
09/30/2010US20100249019 Use of a peptide as a therapeutic agent
09/30/2010US20100249017 Use of cnp-22, alone or in combination with physalemin, as a therapeutic agent
09/30/2010US20100247691 Anti-angiogenic agents and anti-obesity substances applied with anti-angiogenesis from natural products
09/30/2010US20100247688 Pirenzepine and derivatives thereof as anti-amyloid agents
09/30/2010US20100247686 Compositions and methods for obesity, diabetes and metabolic syndrome control and management
09/30/2010US20100247673 Thyroid protection in sickle cell anemia treatment
09/30/2010US20100247655 Synthesis of Small Particles
09/30/2010US20100247645 Pharmaceutical combination of aliskiren and valsartan
09/30/2010US20100247642 Stable pharmaceutical formulation for a dpp-iv inhibitor
09/30/2010US20100247638 organoleptically improved dietary fiber composition and a process thereof (teestar)
09/30/2010US20100247625 Orally Bioavailable Lipid-Based Constructs
09/30/2010US20100247583 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
09/30/2010US20100247577 Tr1 cells, mesenchymal stem cells and uses thereof
09/30/2010US20100247551 Use of Lipocalin 2 in the Regulation of Insulin Sensitivity
09/30/2010US20100247534 Fused heterocyclic compounds as inhibitors of potassium channel function
09/30/2010US20100247520 Mutated netrin 4, fragments thereof and uses thereof as drugs
09/30/2010US20100247512 Pericellular Collagenase Directs the 3-Dimensional Development of White Adipose Tissue
09/30/2010US20100247506 Formation of stable submicron peptide or protein particles by thin film freezing
09/30/2010US20100247505 Composition for Reducing the Level of Glucose, Malondialdehyde-Modified LDL, Homocysteine and/or C-Reactive Protein in Blood
09/30/2010US20100247501 Foodstuff comprising an extract of a plant of the genus salacia and flavonoid
09/30/2010US20100247482 Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compounds
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010US20100247450 Use of erythropoietin
09/30/2010US20100247439 Dendritic nano-antioxidants
09/30/2010US20100247434 Anti-Angiogenic Extracts from Pomegranate
09/30/2010CA2756853A1 Drug fusions and conjugates
09/30/2010CA2756801A1 Tissue kallikrein for the treatment of pancreatic .beta.-cell dysfunction
09/30/2010CA2756786A1 Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
09/30/2010CA2754416A1 Novel medicament for treating cognitive impairment
09/30/2010CA2754176A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/29/2010EP2233571A1 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAS encoding the same
09/29/2010EP2233498A1 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same
09/29/2010EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation.
09/29/2010EP2233482A1 A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarboxamide hemisuccinate salt
09/29/2010EP2233470A1 Histamine H3 receptor antagonists
09/29/2010EP2233146A1 Therapeutic agent for ulcer
09/29/2010EP2233141A1 Ppharmaceutical compositions coprising polymorphic forms of dehydroepiandrosterone
09/29/2010EP2231688A1 Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof
09/29/2010EP2231671A1 Modulators of cystic fibrosis transmembrane conductance regulator
09/29/2010EP2231666A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders
09/29/2010EP2231660A1 Imidazo [1,2-a] pyridine compounds
09/29/2010EP2231649A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/29/2010EP2231645A2 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231644A2 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231643A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
09/29/2010EP2231619A1 Inhibitors of stearoyl-coa desaturase
09/29/2010EP2231617A1 Benzimidazole compounds
09/29/2010EP2231615A1 Cannabinoid receptor modulators
09/29/2010EP2231603A1 Substituted 3 -hydroxypyridines and pharmaceutical compositions thereof
09/29/2010EP2231600A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders
09/29/2010EP2231588A1 Organic salts of -alanine
09/29/2010EP2231197A2 Methods of generating expanded and re-differentiated adult islet beta cells for use in the treatment of diabetes
09/29/2010EP2231164A1 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
09/29/2010EP2231128A1 Method of treating dysglycemia and glucose excursions
09/29/2010EP2230941A1 Liquid enteral nutritional composition with a low specific protein volume
09/29/2010EP1881850B1 Glp-1 pegylated compounds
09/29/2010EP1863801B1 Benzimidazole derivative and use thereof
09/29/2010EP1615698B1 New amide derivatives and pharmaceutical use thereof
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/29/2010CN1985855B Ginkgo health vinegar recipe and preparing method
09/29/2010CN1872052B Drop pills of simvastatin, and preparation method
09/29/2010CN1820642B Compound adzuki bean fat reducing medicinal food
09/29/2010CN1816549B Inhibitors of phosphatidylinositol 3-kinase
09/29/2010CN1794987B Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
09/29/2010CN1674868B Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent
09/29/2010CN1660064B Nage lieqin self-emulsifying system for releasing medicine
09/29/2010CN1475207B Solid oral dosage mode containing walshaden and hydrochloric thizaine
09/29/2010CN101849014A Chimeric PUFA polyketide synthase systems and uses thereof
09/29/2010CN101849006A Improved antibody molecule
09/29/2010CN101848922A Novel mangiferin calcium salts, the method for its preparation and its use
09/29/2010CN101848735A Novel neurturin conjugates for pharmaceutical use
09/29/2010CN101848720A 糖尿病治疗剂 Therapeutic agents for diabetes
09/29/2010CN101845446A Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
09/29/2010CN101843878A Chinese medicament for treating diabetic cardiopathy
09/29/2010CN101843871A Chinese medicament for treating diabetic acro-necrosis
09/29/2010CN101843870A Chinese medicament for treating diabetic acro-necrosis
09/29/2010CN101843869A Chinese medicament for treating diabetic acro-necrosis
09/29/2010CN101843868A Chinese medicament for treating diabetic acro-necrosis
09/29/2010CN101843866A Chinese medicament for treating diabetic feet
09/29/2010CN101843865A Chinese medicament for treating diabetic acro-necrosis
09/29/2010CN101843864A Chinese medicament for treating diabetic acro-necrosis
09/29/2010CN101843857A Chinese medicament for treating diabetic eyeground pathological changes
09/29/2010CN101843843A Chinese medicament for treating diabetes
09/29/2010CN101843837A Chinese medicament for treating diabetic oculopathy
09/29/2010CN101843836A Chinese medicament for treating diabetic oculopathy
09/29/2010CN101843834A Chinese medicament for treating diabetic eyeground pathological changes
09/29/2010CN101843833A Chinese medicament for treating diabetic nephropathy
09/29/2010CN101843831A Chinese medicament for treating diabetic cardiopathy
09/29/2010CN101843824A Chinese medicament for treating diabetic feet
09/29/2010CN101843807A Chinese medicament for treating diabetic cardiopathy
09/29/2010CN101843805A Chinese medicament for treating diabetic cardiopathy
09/29/2010CN101843803A Chinese medicament for treating diabetic nephropathy
09/29/2010CN101843802A Chinese medicament for treating diabetic acro-necrosis
09/29/2010CN101843788A Chinese medicament for treating diabetic oculopathy
09/29/2010CN101843786A Chinese medicament for treating diabetic eyeground pathological changes
09/29/2010CN101843785A Chinese medicament for treating diabetic eyeground pathological changes
1 ... 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 ... 1298